BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
See all
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
See all
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
Monoclonal Antibody Productivity
Single Use
A Fully Single-Use Downstream Process for Monoclonal Antibodies
A Fully Single-Use Downstream Process for Monoclonal Antibodies
by
Shunsuke Shiina,
Neha Saxena
and 1 more
Apr 17, 2024
Artificial intelligence
Information Technology
Using Artificial Intelligence for Monoclonal Antibody Discovery
Using Artificial Intelligence for Monoclonal Antibody Discovery
by
William Whitford
Apr 17, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
See all
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
See all
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX
Emerging Therapeutics
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
by
Suranjana Sen
Apr 17, 2024
Characterization methodologies
Emerging Therapeutics
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
by
Sanjib Banerjee,
Rajiv Bharadwaj
Apr 17, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Global Markets
From healthcare to health: 'No country can do this alone,' say experts in UAE
From healthcare to health: 'No country can do this alone,' say experts in UAE
by
Millie Nelson
May 14, 2024
2 Min Read
thumbnail
Global Markets
US looks to 2032 as cut-off from Chinese biomanufacturing reliance
US looks to 2032 as cut-off from Chinese biomanufacturing reliance
by
Dan Stanton
May 13, 2024
3 Min Read
Home
Manufacturing
Supply Chain
Supply Chain
thumbnail
Supply Chain
Top Trends in Global Biomanufacturing: 20 Years of Analyzing Biologics Production and Supply
Top Trends in Global Biomanufacturing: 20 Years of Analyzing Biologics Production and Supply
by
Erica L. Friedman
Feb 8, 2024
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior
Supply Chain
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior
by
Eric Langer,
Bob Brooks
Jun 26, 2023
eBook: Working Together Is Key to Bioprocess Sustainability
Supply Chain
eBook: Working Together Is Key to Bioprocess Sustainability
eBook: Working Together Is Key to Bioprocess Sustainability
by
Brian Gazaille,
Brian Fahie
May 30, 2023
Addressing Gaps in US Biomanufacturing Capacity
Bioregions
Addressing Gaps in US Biomanufacturing Capacity
Addressing Gaps in US Biomanufacturing Capacity
by
Matt Gardner
May 23, 2023
eBook: The Post-Pandemic Supply Chain
Supply Chain
eBook: The Post-Pandemic Supply Chain
eBook: The Post-Pandemic Supply Chain
by
Dan Stanton,
Millie Nelson
and 1 more
Mar 27, 2023
How To Achieve DSCSA Compliance by November 2023
Supply Chain
How To Achieve DSCSA Compliance by November 2023
How To Achieve DSCSA Compliance by November 2023
by
Andre Caprio
Feb 9, 2023
Supply Chain
Cell Therapy — Supply Chain Discussions
Cell Therapy — Supply Chain Discussions
Dec 15, 2022
+3
by
Dan Stanton,
Gareth Macdonald
and 3 more
Supply Chain
Managing Patient Data in the Supply Chain
Managing Patient Data in the Supply Chain
Dec 6, 2022
by
Matthew Lakelin
Supply Chain
Future Supply-Chain Needs for Allogeneic Cell Therapies: Why Strategic Partnerships Are Critical
Future Supply-Chain Needs for Allogeneic Cell Therapies: Why Strategic Partnerships Are Critical
Sep 28, 2022
by
Chris McClain,
Gregg Bodnar
Sponsored Content
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
Aug 26, 2022
by
BPI Staff
Supply Chain
For resins, supply chain resilience is key, says Purolite
For resins, supply chain resilience is key, says Purolite
May 20, 2022
|
4 Min Read
by
Millie Nelson
Supply Chain
eBook: Speed to IND — Practical Wisdom for Uncertain Times
eBook: Speed to IND — Practical Wisdom for Uncertain Times
Oct 29, 2021
+5
by
S. Anne Montgomery,
John Hill
and 5 more
Cell Therapies
Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
Apr 26, 2021
by
Maribel Rios,
Brian Gazaille
Supply Chain
eBook: Buffers — Navigating New Demands on Downstream Raw Materials
eBook: Buffers — Navigating New Demands on Downstream Raw Materials
Mar 31, 2021
+2
by
Robert Shaw,
Angela Linderholm
and 2 more
Economics
Don’t Be Forced to Accept a Bad Deal During the COVID-19 Crisis
Don’t Be Forced to Accept a Bad Deal During the COVID-19 Crisis
Dec 17, 2020
by
Gaëtan Pellerin
Sponsored Content
Evolving Business Models to Meet the Future of Healthcare
Evolving Business Models to Meet the Future of Healthcare
Dec 17, 2020
by
Gulam Jaffer
Single Use
The Green Imperative: Part One — Life-Cycle Assessment and Sustainability for Single-Use Technologies in the Biopharmaceutical Industry
The Green Imperative: Part One — Life-Cycle Assessment and Sustainability for Single-Use Technologies in the Biopharmaceutical Industry
Jun 11, 2020
+5
by
Magali Barbaroux,
Brian Horowski
and 5 more
Sponsored Content
Making Media a Priority: An Interview with Susan Riley of Advanced Bioprocessing
Making Media a Priority: An Interview with Susan Riley of Advanced Bioprocessing
Dec 4, 2019
by
BPI Contributor
Supply Chain
From Supplying Components to Providing Total Solutions: Overviewing Supplier Side Capabilities
From Supplying Components to Providing Total Solutions: Overviewing Supplier Side Capabilities
Oct 28, 2019
by
Philip Cherian
Cell Therapies
Supply Chain Solutions for Cell and Gene Therapy Companies
Supply Chain Solutions for Cell and Gene Therapy Companies
Jun 28, 2019
by
BPI Contributor
Single Use
The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production - Part 3: Best Practices for Supplier Selection, Qualification, and Validation to Ensure Supply Chain Security
The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production - Part 3: Best Practices for Supplier Selection, Qualification, and Validation to Ensure Supply Chain Security
Jun 12, 2019
by
Bio-Process Systems Alliance (BPSA)
Sponsored Content
Going Beyond the Simple Customer–Supplier Relationship: Ensuring a High-Quality Supply Chain Through Transparent Partnerships
Going Beyond the Simple Customer–Supplier Relationship: Ensuring a High-Quality Supply Chain Through Transparent Partnerships
Jun 12, 2019
by
Claudio Catallo
Supply Chain
Introduction: The Ins and Outs of Market Demand
Introduction: The Ins and Outs of Market Demand
Dec 14, 2018
by
S. Anne Montgomery
Cell Therapies
Standardizing Human MSCs As Critical Raw Materials in Cell Therapy Products: Streamlining Clinical Translation
Standardizing Human MSCs As Critical Raw Materials in Cell Therapy Products: Streamlining Clinical Translation
Dec 14, 2018
+1
by
Mithu Majumder,
Tim Olsen
and 1 more
Supply Chain
Spray Freeze-Drying Technology: Enabling Flexibility of Supply Chain and Drug-Product Presentation for Biologics
Spray Freeze-Drying Technology: Enabling Flexibility of Supply Chain and Drug-Product Presentation for Biologics
Dec 14, 2018
+2
by
Deirdre Lowe,
Mehak Mehta
and 2 more
Supply Chain
Dual Sourcing of Protein A Resin to Mitigate Supply Chain Risk: A Comparative Study to Determine Equivalence
Dual Sourcing of Protein A Resin to Mitigate Supply Chain Risk: A Comparative Study to Determine Equivalence
Jun 20, 2018
+1
by
Edward K. Koepf,
Greg Evangelist
and 1 more
Cell Therapies
Sourcing Clinical-Grade Human Tissue: Considerations for Supporting Cell Therapy Development and Production
Sourcing Clinical-Grade Human Tissue: Considerations for Supporting Cell Therapy Development and Production
Mar 27, 2018
+6
by
Wayne Vaz,
Afshin Shirazian
and 6 more
Supply Chain
Outsourcing to Enhance Assurance of Supply: Application of Counterintuitive Supply Chain Strategies — A Case Study
Outsourcing to Enhance Assurance of Supply: Application of Counterintuitive Supply Chain Strategies — A Case Study
May 17, 2016
+3
by
Elisabeth Vachette,
Paul Priebe
and 3 more
Regulatory Affairs
Addressing Variability in Product Labeling: Explore Dynamic Labeling for Your Global Enterprise
Addressing Variability in Product Labeling: Explore Dynamic Labeling for Your Global Enterprise
Apr 11, 2016
by
Mike Ward
Supply Chain
Clinical Supply Chain: A Four-Dimensional Mission
Clinical Supply Chain: A Four-Dimensional Mission
Mar 11, 2016
by
Jens Mattuschka
Supply Chain
Standardization of Disposables Design: The Path Forward for a Potential Game Changer
Standardization of Disposables Design: The Path Forward for a Potential Game Changer
Dec 16, 2015
+2
by
David Wolton,
Luke Heaven
and 2 more
Biochemicals/Raw Materials
A Risk-Based Approach to Supplier and Raw Materials Management
A Risk-Based Approach to Supplier and Raw Materials Management
Nov 17, 2015
+1
by
Yuval Shimoni,
Venkatesh Srinivasan
and 1 more
Cell Therapies
The Cell Therapy Supply Chain: Logistical Considerations for Autologous Immunotherapies
The Cell Therapy Supply Chain: Logistical Considerations for Autologous Immunotherapies
Oct 15, 2015
by
Dan O'Donnell
Bioreactors
Bioreactor Design for Adherent Cell Culture: The Bolt-On Bioreactor Project, Part 4 — Process Economics
Bioreactor Design for Adherent Cell Culture: The Bolt-On Bioreactor Project, Part 4 — Process Economics
Sep 23, 2015